[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356714-105":59,"doc-detail-356714-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-use-of-the-hpv-vaccine-in-a-group-of-primarily-unvaccinated-hpv-positive-patients","The use of the HPV vaccine in a group of primarily unvaccinated HPV-positive patients","","Human papillomavirus (HPV) infection remains the most prevalent sexually transmitted viral infection worldwide and a key etiologic factor for cervical and other anogenital cancers. Precancerous HPV-related lesions continue to impose a major clinical and epidemiological burden. This study evaluates the effects of ninevalent HPV vaccination on viral clearance, genotype distribution, and lesion regression in HPV-positive women unvaccinated in childhood, using LBC, genotyping, colposcopy, and biopsy/LEEP.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-use-of-the-hpv-vaccine-in-a-group-of-primarily-unvaccinated-hpv-positive-patients/356714/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-use-of-the-hpv-vaccine-in-a-group-of-primarily-unvaccinated-hpv-positive-patients/356714.png","ImageObject",300,407,{"name":92,"@type":93},"Fahsai","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of this study on HPV vaccination?","Question",{"text":112,"@type":113},"To assess how ninevalent HPV vaccination affects viral clearance, HPV genotype distribution, and lesion regression in HPV-positive women who were unvaccinated in childhood.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were participants selected and what procedures were performed?",{"text":117,"@type":113},"A total of 461 women were enrolled between January 2020 and August 2025 based on abnormal cytology, positive hrHPV tests, or abnormal colposcopic findings; participants underwent LBC, HPV genotyping, colposcopy, and biopsy or LEEP when indicated.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings after ninevalent HPV vaccination?",{"text":121,"@type":113},"Vaccinated women showed significantly lower HPV positivity for any genotype, higher complete remission, higher clearance of Gardasil-specific genotypes, and markedly reduced persistence of identical HPV genotypes compared with unvaccinated controls.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356714,1790519410,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","RESEARCH ARTICLE     \nThe use of the HPV vaccine in a group of primarily unvaccinated HPV-positive patients  \nDominik Pruski a,b, Sonja Millert-Kalińskaa,b, Jakub Żurawskic, Robert Jachd, and Marcin Przybylskia,e  \naDepartment of Obstetrics and Gynecology, District Public Hospital, Poznań, Poland; bMedicorner, Specialised Medical Practice, Poznań, Poland; cDepartment of Immunobiology, Poznan University of Medical Sciences, Poznań, Poland; dDivision of Gynecologic Endocrinology, Jagiellonian University Medical College, Kraków, Poland; eMarcin Przybylski Specialised Medical Practice, Poznań, Poland  \nABSTRACT  \nBackground: Human papillomavirus (HPV) infection remains the most prevalent sexually transmitted viral infection worldwide and a major etiologic factor for cervical and other anogenital cancers. HPV-related precancerous lesions continue to represent a substantial clinical and epidemiological burden. Objective: We aim to assess the effects of ninevalent HPV vaccination on viral clearance, genotype distribution, and lesion regression among HPV-positive women who were unvaccinated in childhood. Methods: We enrolled 461 women between January 2020 and August 2025 to the study who presented with abnormal cytology, positive hrHPV tests, or abnormal colposcopic findings. Participants underwent LBC, HPV genotyping, colposcopy, and biopsy or LEEP when indicated. The vaccinated cohort (n = 351) received the Gardasil®9 series (0–2–6 months), while 110 women served as unvaccinated controls. Statistical analyses were performed using R software (v4.4.2) with a significance threshold of α = 0.05. Results: Following vaccination, HPV positivity for any genotype was significantly lower in the vaccinated group than in the control group (29.3% vs 56.4%, p \u003C .001) . Clearance of Gardasil-specific genotypes occurred in 83.5% of vaccinated women compared with 63.6% in the controls. Complete remission was higher in the vaccinated group (70.7% vs 43.6% in the control group) . Persistence of identical HPV genotypes was markedly reduced after vaccination (8.5% vs 27.3%) . Conclusions: Nine-valent HPV vaccination significantly enhanced viral clearance and reduced persistence and recurrence of high-grade squamous intraepithelial lesions (HSIL) among previously unvaccinated HPV-positive women. These findings support extending vaccination recommendations to adult HPV-positive patients as an adjunctive strategy to surgical and cytologic management.  \nARTICLE HISTORY  \nReceived 1 February 2026 Revised 8 April 2026 Accepted 17 April 2026  \nKEYWORDS  \nHPV-positive; SIL; HSIL; HPV infection; HPV vaccination; 9-valent vaccination; HPV remission; HPV clearance; HPV regression  \nIntroduction  \nConditions related to human papillomavirus (HPV) constitute a significant health problem worldwide. 1 HPV infection is the most common sexually transmitted viral infection.2 In high-income countries (HICs), where cervical cancer (cc) incidence and mortality rates have significantly decreased, precancerous conditions of the cervix, vulva, and vagina remain a real health concern.3,4 In approximately 90% of HPV infections, spontaneous regression can occur, and this is observed more frequently in younger patients, while persistent infection occurs in a smaller percentage. Persistent infection with oncogenic HPV types leads to the development of squamous intraepithelial lesions (SIL), which can lead to cervical cancer in women. Similarly, complete regression of LSIL occurs significantly more frequently in younger women than in older women, and the risk of progression to HSIL is higher.5 HPV-related diseases are a clinical problem not only for surgeons and gynecologists, but also for otolaryngologists and dentists. In otolaryngology, the incidence and mortality rates for HPV-related head and neck cancers continue to decline and are even gradually increasing in both women and men.6  \nDue to the long-term asymptomatic and insidious nature of precancerous lesions, the greatest cha","cbCaibPI1sFKAWpb","https://ap.wps.com/l/cbCaibPI1sFKAWpb","pdf",3108520,12,"English","# Abstract\n## Background and Objective\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Burden of HPV and persistence\n## Clinical challenge in gynecologic oncology\n## Diagnostic and molecular approaches","[{\"question\":\"What is the main objective of this study on HPV vaccination?\",\"answer\":\"To assess how ninevalent HPV vaccination affects viral clearance, HPV genotype distribution, and lesion regression in HPV-positive women who were unvaccinated in childhood.\"},{\"question\":\"How were participants selected and what procedures were performed?\",\"answer\":\"A total of 461 women were enrolled between January 2020 and August 2025 based on abnormal cytology, positive hrHPV tests, or abnormal colposcopic findings; participants underwent LBC, HPV genotyping, colposcopy, and biopsy or LEEP when indicated.\"},{\"question\":\"What were the key findings after ninevalent HPV vaccination?\",\"answer\":\"Vaccinated women showed significantly lower HPV positivity for any genotype, higher complete remission, higher clearance of Gardasil-specific genotypes, and markedly reduced persistence of identical HPV genotypes compared with unvaccinated controls.\"}]","The use of the HPV vaccine in a group of primarily unvaccinated HPV-positive patients | PDF",1790126912,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/04435a88435592b0ffafd08e2f737434.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/86546b3258faf3ee29aa53dc79247a4e.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5dbafc6e0cde37eda8380adea098df28.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df0decc2bfcb9748030d2c5a6cca19ed.webp",980,1306]